New drug for advanced solid tumors
Part of Cancer clinical trials.
This trial is testing a new drug called KY-0301 for people with advanced solid tumors that haven't responded to other treatments. It aims to see if the drug is safe and effective, and it will be given in two parts to find the right dose and for specific cancer types.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You have an advanced solid tumor cancer that has spread or can't be removed by surgery, and you've already tried standard treatments or can't take them.
- You weigh at least 45 kg (about 99 pounds) if female, or 50 kg (about 110 pounds) if male, and have a BMI of 18 or more.
- Your cancer is one of these types: non-small cell lung cancer (and you've had certain prior treatments), colorectal cancer (after 3 or more lines of chemo), or another solid tumor that fits the study's criteria.
- You have not had severe allergic reactions to a certain type of treatment in the past.
- You don't have active infections like HIV, hepatitis B or C, or other serious medical issues like unstable heart disease or brain metastases that cause symptoms.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental drug, BA1203, for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if the drug is safe and whether it can help shrink tumors.
This trial tests a new drug called KH801, which may help the immune system fight cancer. It's for people whose cancer has spread or can't be removed and who have already tried other treatments without success. The goal is to see if the drug is safe and if it helps slow down the cancer.
This Phase 1 trial studies how a new medicine (KC1036) works and how safe it is for people with advanced solid cancers that have grown despite standard treatments. It may help future patients by showing whether the drug can control cancer in difficult-to-treat cases.
This trial tests an experimental drug called KM602 for people with advanced solid tumors that have stopped responding to standard treatments, particularly melanoma and non-small cell lung cancer. It aims to see if the drug is safe and effective in shrinking or controlling tumors.
This trial tests a new drug, SYHA1813, given alone or with other treatments, for people with advanced solid tumors that cannot be removed by surgery or have spread. The goal is to see if it is safe and effective.
This trial tests a new oral drug (CS231295) for people with advanced solid tumors who have run out of standard options. It aims to see how safe the drug is and how well it controls the cancer, and may slow tumor growth. You must be in reasonably good health with adequate organ function.
Hear when a new Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.